Growth Factor Injections for Hair Loss: Does QR678 Actually Work?
Growth factor injections such as QR678 are increasingly marketed as a drug-free way to regrow hair, an appealing pitch for anyone wary of minoxidil or finasteride. The honest answer to "does it work" is more interesting than either the glowing clinic websites or the dismissive skeptics suggest. There is real human data behind it, and a significant catch the marketing quietly leaves out. Here is the balanced picture, and how it stacks up against treatments you can already do yourself.
The honest verdict, up front
QR678 is a promising clinic treatment with genuine human studies behind it, but it is not proven to the standard of minoxidil and finasteride. Most of its research comes from the same group that developed it, and much of it lacks the independent, blinded design that settles these questions. Reasonable as an in-clinic add-on for some people. Not a replacement for the proven, self-applied basics.
What QR678 Actually Is
Start with what is being injected, because the name reveals little.
QR678, and its newer version QR678 Neo, is an injectable cocktail of growth factors, the signalling molecules that tell follicles to grow. The formula includes VEGF, basic FGF, IGF-1, and keratinocyte growth factor, plus a copper peptide, delivered into the scalp with fine intradermal injections over several sessions. It was developed by a Mumbai clinic and offered as a procedure, not a product, the first practical difference from something like a minoxidil and finasteride topical solution you apply yourself at home. The idea is sound in principle: flood the follicle with the growth signals it uses naturally. The question, as always, is whether that principle holds up when properly tested in people.
The Case For It
To be fair to the treatment, the supporting research is not trivial, and it deserves a fair hearing.
The largest study is a Phase IV trial reporting on 2,428 patients with male and female pattern hair loss, which found the treatment effective and well tolerated. Separate studies have compared it against PRP (platelet-rich plasma), and against a combination of the injections with minoxidil and finasteride, while smaller trials have looked at specific groups such as women with PCOS-related hair loss and people with hair shedding after Covid. On paper, that is more human data than many trendy hair treatments can point to, and the results reported have generally been positive. For a follicle-signalling approach, it is a more serious body of evidence than, say, most over-the-counter serums built on branded cosmetic actives can claim.
The Catch the Marketing Skips
Here is where honesty matters, because this single point should shape how much weight you give all those studies.
The great majority of published QR678 research comes from the same group that developed and commercialised the treatment, and much of it is open-label or single-arm rather than independent, double-blind, placebo-controlled. That does not make the results fake or the treatment useless. But in medicine, the strongest evidence is independent and blinded precisely because it removes the influence of people with a stake in the outcome. Until other research teams replicate these findings in rigorous designs, QR678 sits in the "promising, not settled" category, the same honest bar we apply to branded hair actives and to much of the wider pipeline. Judge it by that standard, and the fair verdict is cautious optimism, not certainty.

How It Compares to What You Can Do Yourself
The practical question is not just "does it work" but "is it worth it, versus the alternatives."
QR678 is administered in a clinic, needs multiple sessions, costs far more than topical treatment, and its results are not established as permanent, so maintenance is typically needed. Minoxidil and finasteride, by contrast, are proven, inexpensive, self-applied, and backed by decades of independent trials. For most people with pattern hair loss, the sensible first step is the proven, affordable basics used consistently, not an expensive procedure whose evidence is still maturing. If you want stronger support without a clinic, a self-applied option like Xtra Hair Pro or the hair fall solution range generally offers better value and firmer evidence.
Evidence Scorecard: QR678 at a Glance
To weigh it fairly, here is how QR678 rates on the measures that actually matter.
|
Measure |
How QR678 rates |
|
Mechanism plausibility |
Strong. Growth factors genuinely drive follicle activity |
|
Volume of human data |
Good. Thousands of patients across several studies |
|
Independent, blinded evidence |
Weak. Mostly same-group, open-label designs |
|
Compared to proven basics |
Unproven as superior; more costly and less convenient |
|
Results permanent? |
Not established; maintenance likely needed |
The pattern is consistent with the honest verdict at the top: a plausible mechanism and a fair amount of data, held back by the quality and independence of that data.
Who Might Reasonably Consider It
None of this means QR678 is a bad choice for everyone. There are sensible cases for it.
It may suit people who cannot tolerate or do not wish to use drug-based treatments, those who have plateaued on topicals and want an in-clinic add-on under medical supervision, or specific cases a dermatologist judges a good fit. Even then, it works best as a complement to a solid foundation, not a standalone miracle. Women in particular should be careful to choose women-appropriate care overall, since the drug half of standard men's treatment is unsafe for them, as covered in our guide to hair loss treatment for women. Whatever you add on top, the proven base should usually come first.
Frequently Asked Questions
Does QR678 actually work for hair loss?
There is genuine human evidence that it can help, including a large study of over 2,400 patients reporting positive results. However, most of that research comes from the group that developed it and often lacks independent, blinded design, so it is best described as promising rather than proven to the standard of minoxidil and finasteride.
What are the side effects of QR678?
In the published studies it was generally reported as well tolerated, with the usual risks associated with any injectable procedure, such as temporary discomfort, redness, or swelling at the injection sites. As with any clinic treatment, it should be performed by a qualified professional.
Is QR678 permanent?
No, its results are not established as permanent. Like most hair-loss treatments, ongoing maintenance sessions are typically needed to sustain any benefit, which is part of why cost and convenience matter when comparing it to self-applied options.
Kya QR678 waqai kaam karta hai?
Iske peeche asli human evidence maujood hai, jismein 2,400 se zyada mareezon ki ek bari study bhi hai jis ke natije positive thay. Lekin zyada tar research usi group ki hai jisne isay banaya, aur aksar independent blinded design nahi rakhti. Is liye yeh "promising" hai, minoxidil aur finasteride ki tarah proven nahi.
Kya QR678 minoxidil se behtar hai?
Sabit nahi. Minoxidil aur finasteride sasti, khud lagane wali, aur decades ki independent trials se proven hain. QR678 clinic mein hoti hai, mehngi hai, aur permanent nahi. Zyada tar logon ke liye pehle proven basics behtar hain, QR678 sirf ek add-on ke tor par doctor ki nigrani mein.
The Bottom Line
QR678 occupies an honest middle ground. It is not the breakthrough its marketing implies, and it is not a scam either. It rests on a sound biological idea and a real, if imperfect, body of human evidence, held back mainly by the fact that most of that evidence comes from a single interested source rather than independent, blinded trials. That makes it a reasonable in-clinic add-on for some people, under medical guidance, but not a substitute for the proven, affordable, self-applied basics that should anchor any hair-loss plan. Start with what is proven, add newer options only once your foundation is solid, and hold every treatment to the same standard of evidence. Compare the proven options in the hair fall solution collection and the wider hair care range, and understand the normal early minoxidil shedding phase before judging any treatment too soon.
References
- Phase IV multi-ethnicity trial of the QR678 growth-factor formulation in androgenetic alopecia and female pattern hair loss (2,428 patients).
- Kapoor R, Shome D. First-in-man pilot study of the QR678 hair-growth factor formulation. J Cosmet Laser Ther, 2018.
- Comparative studies: QR678 versus PRP, and QR678 with minoxidil and finasteride; QR678 in PCOS-related female pattern hair loss.
This article is educational and not medical advice. QR678 is a clinic-administered procedure that should be performed and advised on by a qualified professional. Consult one before choosing any treatment.